carmustine has been researched along with Leukemia, Plasmacytic in 7 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 7.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| "A 53-year-old man with multiple myeloma and plasma cell luekemia developed severe, acute bilateral optic neuroretinitis 8 days after chemotherapy with BCNU, procarbazine, cyclophosphamide, and prednisolone." | 3.66 | Optic neuroretinitis in association with BCNU and procarbazine therapy. ( Lennan, RM; Taylor, HR, 1978) |
| "We report a case of de novo plasma cell leukemia, resistant to standard VMD (vincristine, mitoxantrone, dexamethasone) and CVP (cyclophosphamide, vincristine and prednisone) protocols, treated with a chemotherapy intensification regimen (high-dose cyclophosphamide, modified EDAP, Dexa-BEAM) and peripheral blood stem cell transplantation, performed using fractionated total body irradiation and high dose melphalan." | 1.29 | Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report. ( Bonini, A; Carotenuto, M; Cascavilla, N; D'Arena, G; Di Mauro, L; Greco, MM; Melillo, L; Minervini, MM; Musto, P; Sajeva, MR; Scalzulli, P, 1996) |
| "A case of non-secretory multiple myeloma presenting as primary plasma cell leukaemia in a 65 year old woman is presented." | 1.28 | Non-secretory multiple myeloma presenting as primary plasma cell leukaemia. ( Hernando, JC; Pais, JR; Pascual, J; Pérez Vaquero, MA; Sureda, A, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sajeva, MR | 1 |
| Greco, MM | 1 |
| Cascavilla, N | 1 |
| D'Arena, G | 1 |
| Scalzulli, P | 1 |
| Melillo, L | 1 |
| Minervini, MM | 1 |
| Bonini, A | 1 |
| Di Mauro, L | 1 |
| Carotenuto, M | 1 |
| Musto, P | 1 |
| Lennan, RM | 1 |
| Taylor, HR | 1 |
| Emmerich, B | 1 |
| Maurer, R | 1 |
| Schmidt, G | 1 |
| Rastetter, J | 1 |
| Sureda, A | 2 |
| Pais, JR | 1 |
| Pascual, J | 1 |
| Pérez Vaquero, MA | 1 |
| Hernando, JC | 1 |
| Pérez de Oteyza, J | 1 |
| García Laraña, J | 1 |
| Odriozola, J | 1 |
| Morey, M | 1 |
| Bargay, J | 1 |
| Galmes, A | 1 |
| Besalduch, J | 1 |
| Krsnik, I | 1 |
| Peñalver, MA | 1 |
| Del Potro, E | 1 |
| Diaz-Mediavilla, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "Mézières Method for The Use of Self in People With Low Back Pain. Mixed Study."[NCT03738306] | Early Phase 1 | 40 participants (Anticipated) | Interventional | 2019-02-28 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for carmustine and Leukemia, Plasmacytic
| Article | Year |
|---|---|
Effective autologous peripheral blood stem cell transplantation in plasma cell leukemia followed by T-large granular lymphocyte expansion: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Cyclophosphamide; Cyta | 1996 |
Optic neuroretinitis in association with BCNU and procarbazine therapy.
Topics: Carmustine; Drug Therapy, Combination; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Multiple My | 1978 |
[Effect of several chemotherapeutic agents on protein synthesis in leukemic plasma cells (author's transl)].
Topics: Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Humans; Immunoglobulins; Leukemia, | 1979 |
Non-secretory multiple myeloma presenting as primary plasma cell leukaemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; | 1992 |
[Complete double remission and prolonged survival of a patient diagnosed with plasma cell leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Leukemia, Plas | 1989 |
[Plasma cell leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Humans; Leukemia, Plasma Ce | 1989 |
Complete remission in plasma cell leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Humans; Leukem | 1987 |